Features and Benefits
Withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH. Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage. Oriented coupling of recombinant Protein A to the matrix via an engineered C-terminal cysteine enhances IgG binding capacity. Fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification. Prepacked HiTrap columns for process development, screening of purification conditions, and small-scale purification of Mabs.
General description
HiTrap MabSelect SuRe columns are prepacked with MabSelect SuRe, a BioProcess medium for purification of monoclonal antibodies from large sample volumes. The novel alkali-tolerant recombinant Protein A ligand allows cleaning-in-place (CIP).
Legal Information
MabSelect SuRe is a trademark of Cytiva
Free MabSelect SuRe Ligand"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
HiTrap is a registered trademark of Cytiva
This product has met the following criteria to qualify for the following awards: